Cargando…
Endocannabinoids
There is currently considerable interest in the development of medicines that would enhance endocannabinoid-induced "autoprotection", for example through inhibition of endocannabinoid metabolizing enzymes or cellular uptake processes or that would oppose endocannabinoid-induced "autoi...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Cham :
Springer International Publishing : Imprint: Springer,
2015.
|
| Edición: | 1st ed. 2015. |
| Colección: | Handbook of Experimental Pharmacology,
231 |
| Temas: | |
| Acceso en línea: | Texto Completo |
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-3-319-20825-1 | ||
| 003 | DE-He213 | ||
| 005 | 20220115105714.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 150925s2015 sz | s |||| 0|eng d | ||
| 020 | |a 9783319208251 |9 978-3-319-20825-1 | ||
| 024 | 7 | |a 10.1007/978-3-319-20825-1 |2 doi | |
| 050 | 4 | |a RM300-666 | |
| 072 | 7 | |a MMG |2 bicssc | |
| 072 | 7 | |a MED071000 |2 bisacsh | |
| 072 | 7 | |a MKG |2 thema | |
| 082 | 0 | 4 | |a 615 |2 23 |
| 245 | 1 | 0 | |a Endocannabinoids |h [electronic resource] / |c edited by Roger G. Pertwee. |
| 250 | |a 1st ed. 2015. | ||
| 264 | 1 | |a Cham : |b Springer International Publishing : |b Imprint: Springer, |c 2015. | |
| 300 | |a XII, 475 p. 21 illus., 15 illus. in color. |b online resource. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file |b PDF |2 rda | ||
| 490 | 1 | |a Handbook of Experimental Pharmacology, |x 1865-0325 ; |v 231 | |
| 520 | |a There is currently considerable interest in the development of medicines that would enhance endocannabinoid-induced "autoprotection", for example through inhibition of endocannabinoid metabolizing enzymes or cellular uptake processes or that would oppose endocannabinoid-induced "autoimpairment". This volume describes the physiology, pathophysiology and pharmacology of the endocannabinoid system and potential strategies for targeting this system in the clinic. | ||
| 650 | 0 | |a Pharmacology. | |
| 650 | 0 | |a Cytology. | |
| 650 | 0 | |a Neurosciences. | |
| 650 | 0 | |a Psychiatry. | |
| 650 | 0 | |a Immunology. | |
| 650 | 0 | |a Cytokines. | |
| 650 | 1 | 4 | |a Pharmacology. |
| 650 | 2 | 4 | |a Cell Biology. |
| 650 | 2 | 4 | |a Neuroscience. |
| 650 | 2 | 4 | |a Psychiatry. |
| 650 | 2 | 4 | |a Immunology. |
| 650 | 2 | 4 | |a Cytokines and Growth Factors. |
| 700 | 1 | |a Pertwee, Roger G. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9783319208244 |
| 776 | 0 | 8 | |i Printed edition: |z 9783319208268 |
| 776 | 0 | 8 | |i Printed edition: |z 9783319371191 |
| 830 | 0 | |a Handbook of Experimental Pharmacology, |x 1865-0325 ; |v 231 | |
| 856 | 4 | 0 | |u https://doi.uam.elogim.com/10.1007/978-3-319-20825-1 |z Texto Completo |
| 912 | |a ZDB-2-SBL | ||
| 912 | |a ZDB-2-SXB | ||
| 950 | |a Biomedical and Life Sciences (SpringerNature-11642) | ||
| 950 | |a Biomedical and Life Sciences (R0) (SpringerNature-43708) | ||